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Abstract
Ablation of host submaxillary glands modifies Ehrlich tumor growth
and tumor-infiltrating leukocytes, possibly by modifications in the
serum level of growth factors produced by this gland. To extend this
research, 7-month-old male EPM-1 mice (N = 30) were divided into
two groups: 1) inoculated with tumor cells previously incubated with
submaxillary salivary gland extract (SGE) in PBS for 30 min at 37%;
2) inoculated with tumor cells previously incubated with PBS, under
the same conditions. Animals were inoculated into the footpad with 40
µl of a suspension containing 4.5 x 107 tumor cells/ml, and footpad
thickness was measured daily for 10 days. Sections and smears of
tumor cells were prepared from the tumor mass to determine mitosis
frequency, percent of tumor cells immunopositive to nerve (NGF) and
epidermal (EGF) growth factors and percent of tumor-infiltrating
leukocytes. The incubation of tumor cells with SGE produced a tumor
reduction of about 30% in size (P<0.01). This effect was not related to
loss of cell viability during incubation, but a 33% increase (P<0.05) in
the percentage of dead or dying tumor cells and a 15% increase in the
percent of NGF/EGF-positive tumor cells (P<0.01) were observed in
vivo at the end of experiment. Tumor-infiltrating lymphocytes and
mitosis frequency did not differ between groups. These data suggest a
direct effect of factors present in SGE on tumor cells, which induce
degeneration of tumor cells.
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The submaxillary salivary gland of mice
and of other species has multiple functions in
the body, including digestive, endocrine and
immune functions (1). It produces and se-
cretes several active peptides, some of which
are growth factors, such as nerve growth
factor (NGF), epidermal growth factor (EGF)
(2) and a-fetoprotein (3), which might be
important for the growth of several tumors.
Experimental studies on nude mice have
shown that EGF administration and siaload-
enectomy can modify human gastric tumor
growth in nude mice (4).
We have demonstrated that the ablation
of the submaxillary salivary glands in mice
produces a significant decrease in Ehrlich
tumor growth associated with an increase in
NK cell population inside the tumor mass
(5). The present study was undertaken to
extend this research by using Ehrlich tumor
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cells pre-incubated with a submaxillary gland
extract (SGE).
Seven-month-old male EPM-1 mice
weighing 35 to 45 g, housed under condi-
tions of controlled temperature (25 – 3oC)
and light (12-h light/12-h dark, lights on at
6:00 a.m.), with food and water ad libitum,
were used. The 7-month age of the animals
was determined on the basis of previous data
indicating that effects of growth factors are
more evident in old animals (5).
The ascitic form of Ehrlich tumor was
used to maintain tumor cells in our labora-
tory. For the experimental procedures, 3 to 4
ml of ascitic fluid from mice inoculated 12
days before were collected and centrifuged
at 140 g for 10 min. The supernatant was
discarded and tumor cells were resuspended
in phosphate-buffered saline (PBS), pH 7.2.
The washing procedure was repeated 3 times.
The Trypan blue exclusion test was used
to determine the percentage of living cells,
which were counted in a modified Neubauer
chamber. Cell viability was always at least
90%, and the cell concentration for inocula-
tion was 4.5 x 107 viable cells/ml.
SGE was prepared by the method of Skin-
ner et al. (6). One hundred pairs of submax-
illary glands were harvested from adult male
mice and homogenized with a manual tissue
homogenizer and 0.3 ml of 0.2% (w/v) soy-
bean trypsin inhibitor (Sigma Chemical Co.,
St. Louis, MO, USA) and 7.7 ml PBS/g
gland were added at 4oC. The homogenate
was centrifuged at 20,000 g for 30 min at 4oC
and the supernatant was stored at -30oC until
use.
Before inoculation, an aliquot of the cell
suspension was incubated 1:1 with SGE for
30 min at 37oC. The remaining cells were
incubated with PBS for the same period of
time and at the same temperature and pro-
portion. Another Trypan blue exclusion test
was carried out immediately after incubation
to determine cell viability. A total of 0.04 ml
of these suspensions was inoculated into the
hind footpad of mice, and paw thickness was
measured daily for 10 days with a microme-
ter. The first measurement was made before
tumor inoculation.
Mice were divided into two groups of 15
animals each: 1) mice inoculated with tumor
cells previously incubated with SGE (group
IE); 2) mice inoculated with tumor cells
previously incubated with PBS (group IB).
After 11 days of tumor growth, animals
were sacrificed and footpads removed. Foot-
pads from half of the mice were fixed in 10%
paraformaldehyde and processed histologi-
cally by usual embedding and staining meth-
ods (hematoxylin-eosin). These sections were
used to count the number of mitoses per
field, in five standard fields (40X) of each
footpad section. A single cell suspension
was obtained from the remaining footpads
by mechanical dissociation of tumor cells in
PBS. Several smears were prepared, fixed
in 100% methanol at 4oC for 10 min and
stained by the immunocytochemical or Pa-
panicolaou (PAP) method. All procedures
were carried out using plastic material to
avoid macrophage adhesion.
The Papanicolaou-stained smears were
used to count the percentage of tumor cells
and leukocytes and to differentiate viable
cells from dead or dying tumor cells, macro-
phages and lymphocytes. Two hundred cells
were counted in each smear. Degenerating
cells were identified by volume reduction,
cytoplasm irregularity, nuclear fragmenta-
tion and pyknosis.
The immunocytochemical procedure was
carried out to identify NGF- and EGF-posi-
tive cells by the PAP method, using 0.1%
periodic acid to block endogenous peroxi-
dase activity and diaminobenzidine (Sigma)
for developing, as described before (7). Nu-
clei were stained with Harry hematoxylin. A
negative control was prepared with PBS re-
placing primary antibodies, used at 1:50 di-
lution and incubated at 37oC for 30 min. A
positive control was prepared with frozen
sections of submaxillary salivary glands. Two
hundred cells per smear were counted.
1207
Braz J Med Biol Res 32(10) 1999
Growth factors and Ehrlich tumor
Statistical analysis was performed using
the Student t-test for tumor growth measure-
ment (experimental x control) and the Fisher
test for cell counts. The level of significance
was established at P£0.05.
There was a reduction of about 30% in
tumor size when the tumor was previously
incubated with SGE (Figure 1). There also
was a 50% increase in the number of dead
and dying cells in the group inoculated with
SGE-pre-incubated tumor cells in relation to
the control group, but the percentage of tu-
mor-infiltrating macrophages and lympho-
cytes did not change. The percentages ob-
served were 61% macrophages and 39%
lymphocytes for the IE group and 49% mac-
rophages and 51% of lymphocytes for the IB
group. Cell viability did not change during
incubation, as demonstrated by the Trypan
blue test (data not shown).
No differences were observed in number
of mitoses per field (data not shown), but the
percent and the staining intensity of NGF/
EGF-positive cells were higher in tumors
whose cells had been incubated with SGE
before inoculation (IE group) in relation to
the control (IB group) (Table 1 and Figure
2).
The effects of SGE on tumor growth
seem to vary with type of treatment. The
incubation of tumor cells with SGE a few
minutes before inoculation into the footpad
induced a marked reduction in tumor growth
and an increase in the percentage of degener-
ated and NGF/EGF-positive cells compared
to PBS-incubated group. These data suggest
a direct interaction of one or more sub-
stances present in SGE with tumor cells
during incubation, which could trigger intra-
cellular mechanisms of cell destruction. This
cell death would occur only after cell inocu-
lation, because cell viability did not change
immediately after incubation, excluding the
possibility of cells being killed during ma-
nipulation. Thus, cell death occurred in vivo.
The reduction in tumor proliferation is
not probable, because the number of mitoses
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Figure 1 - Inhibition of tumor size
by preincubation of Ehrlich cells
with an extract of submandibu-
lar gland cells (SGE; IE group) or
PBS (IB group). The experiment
is described in the legend to
Table 1. Data are reported as
means ± SD tumor size.
*P<0.01 compared to IB group
(Student t-test).
Figure 2 – Photomicrograph
showing the NGF/EGF-positive
tumor cells in groups IB (A) and
IE (B). Note the differences in
staining intensity between A and
B.
did not change. The presence of tumor-infil-
trating leukocytes was similar for the IE and
IB groups, suggesting that tumor death was
not determined by a cellular and/or inflam-
matory response to the tumor. However, it is
known that NGF binding to neural cells in-
duces apoptosis (8), and therefore a possible
role of apoptosis mechanisms in the inhibi-
tion of Ehrlich tumor growth by SGE should
be considered.
*
* *
* *
* *
*
*
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These results appear to contradict those
reported in previous studies, in which abla-
tion of the submaxillary gland increased tu-
mor infiltrating NK cells and reduced tumor
growth (5), but the relation between biologi-
cally active factors from the submaxillary
gland and tumor growth is highly complex
and could be related either to cell degenera-
tion or to cell differentiation and death (9).
Thus, the response of tumor cells to with-
drawal of endogenous factors by sialoade-
nectomy is not necessarily the opposite of
their response to overexposure to the same
submaxillary gland factors. On the other hand,
direct cell treatment and overexposure to
SGE decreased Ehrlich tumor development
in vivo.
The inhibitory activity of excessive stim-
uli on biologic systems has been described
by several investigators and was defined in
the past as hormesis or Arndt-Schulz law:
A stimulus on a living cell elicits an activ-
Table 1 - Effect of pre-incubation of Ehrlich tumor
cells on tumor viability and growth factor staining
after inoculation into mouse foot pads.
The cells were incubated with an extract of sali-
vary gland (IE) or PBS (IB) and inoculated into the
foot pads of mice. Foot pad smears were ob-
tained 11 days after inoculation and the distribu-
tion of tumor cells is based on counting 200 cells.
Data are reported as means ± SD for 15 animals in
each group. NGF, Nerve growth factor; EGF, epi-
dermal growth factor. *P<0.05 compared to con-
trol group (Fisher test).
Groups Tumor cells (%)
Dead Live NGF + tumor EGF + tumor
IE 45* 55 16* 12*
IB 12 88 7 1
ity, which is inversely proportional to the
intensity of the stimulus. This law was for-
gotten and even refuted by early scientists,
but today it is known that some biological
phenomena can present this behavior, such
as corticoids in relation to macrophage ac-
tivity and lymphocyte anergy after overex-
posure to antigens (10).
The substances that would lead to cell
death in the present case are unknown, but
the marked increase in staining and percent-
age of NGF/EGF-positive tumor cells incu-
bated with SGE suggests that these growth
factors themselves could be related to tumor
cell death. In fact, this view is supported by
the intra-nuclear immunohistochemical stain-
ing for NGF in Ehrlich tumor cells observed
in previous studies (11). Tumor regression
with NGF super-stimulation has been previ-
ously reported in human prolactinomas (12).
In addition, tumor growth inhibition by NGF
was observed also in rat T9 anaplastic glioma
cells, in a dose-dependent manner, and was
attributable to a gradual accumulation of
growth-arrested cells at the G1 phase (13).
Although in the present study the specif-
ic role of NGF/EGF in tumor growth changes
was not determined, the unexpected inhibi-
tory response of tumor cells when incubated
with SGE could indicate a non-linear rela-
tionship between submaxillary salivary gland
factors and tumor growth, whatever the
factor(s) involved. This finding raises the
question about the possibility of the same
response being obtained with apparently
opposite stimuli (ablation of the gland or
overexposure during incubation with the
gland extract) and the necessity to under-
stand this pattern of biological facts.
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